Thyrotropin Binding Inhibiting Antibody (TBIAb) in Graves’ Disease
To determine the nature of TBIAb in Graves’ disease, TBIAb was measured and correlated to various clinical, thyroid functional indices and thyroid autoantibodies.
Main Authors: | Cho, Won Yong, Choi, Hyang Hee, Chun, Hun Jae, Ahn, Il-Min |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Association of Internal Medicine
1988
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532134/ |
Similar Items
-
Changes in the Properties of the Thyrotropin Receptor Antibody in Patients with Graves’ Disease after Radioiodine Treatment
by: Cho, Bo Youn, et al.
Published: (1990) -
Graves' Patient with Thymic Expression of Thyrotropin Receptors and Dynamic Changes in Thymic Hyperplasia Proportional to Graves' Disease Activity
by: Song, Young Shin, et al.
Published: (2016) -
Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
by: Inaba, Hidefumi, et al.
Published: (2016) -
Negative correlation between the conversion of thyrotropin receptor-bound blocking type thyrotropin receptor antibody to the stimulating type by anti-human IgG antibodies and the biological activity of blocking type thyrotropin receptor antibody.
by: Cho, B. Y., et al.
Published: (1993) -
Islet Cell Surface Antibodies in Graves’ Disease; As Organ Non-Specific Antibodies
by: Ahn, Il-Min, et al.
Published: (1988)